Terumo Corporation · TSE:4543
Terumo — Investor Presentation (December 2021)
18 slides from Terumo's investor presentation, Dec 16, 2021
Slide 1: General Hospital Company: 5-Year Growth Strategy with a 10-Year Vision
Celebrating our 100th founding anniversary: 5-Year Growth Strategy with a 10-Year Vision 03 | General Hospital Company Hikaru Samejima, President ©TERUMO CORPORATION 1 / 17
Slide 2: Safe Harbor for Forward-Looking Statements and Use of Document
Safe Harbor for Forward-Looking Statements and Use of Document Among the information that Terumo discloses, the forward-looking statements including financial projections are based upon our assumptions using information available to us at the time and are not intended to be guarantees of future even
Slide 3: Vision for our 5-Year Growth Strategy
Vision for our 5-Year Growth Strategy We provide patient centered solutions that integrate our unique technologies, contributing to the advancement of high quality, innovative medical care. ©TERUMO CORPORATION 3 / 17
Slide 4: Our Core Competencies
Our Core Competencies Diabetes (insulin delivery) solutions Drug delivery solutions for pharmaceutical companies (DM & consumer health care) (Alliance) IV drug delivery solutions Peritoneal dialysis solutions (General hospital products) (Pharmaceutical) Medical safety, efficiency Drug delivery techn
Slide 5: Looking Back on Current Mid- to Long-term Growth Strategy
Looking Back on Current Mid- to Long-term Growth Strategy Summary of current mid- to long-term growth strategy Adjusted operating profit % Achievements 16.8% 16.2% Enhanced product portfolio by focusing on the diabetes treatment field 15.5% 14.8% 14.7% Acquired big projects from pharmaceutical c
Slide 6: Key Shifts in Market
Key Shifts in Market Market Dynamics Strategic implications Shift value proposition to the whole care which covers hospitals Change in care paradigm and home by focusing on patient-centric care Maturation of Japan market Accelerate global expansion to the US, China, other markets Provide pharmaceuti
Slide 7: 5-Year Growth Strategy: General Hospital Company
5-Year Growth Strategy: General Hospital Company Hospital Care Propose solutions to solve hospital management and front-line Solutions issues by improving infection rate, equipment efficiency, etc. Propose patient-centric and personalized solutions for chronic Life Care diseases in outpatient and ho
Slide 8: Growth Opportunities through Business Solutions in Hospital Business
Hospital Care Solutions Growth Opportunities through Business Solutions in Hospital Business Drug delivery solutions Infection control solutions Develop safe and efficient drug delivery solutions Analyze infection related data and propose solutions that improve infection rates and hospital operation
Slide 9: DM: Accelerate Personalization with Solution Offerings that Leverage Outside Collaboration
Life Care Solutions DM: Accelerate Personalization with Solution Offerings that Leverage Outside Collaboration Glooko (US) MICIN (Japan) Diabeloop (France) Collaboration Joint development Joint development Information Management System Digital Healthcare Support Automated Insulin Delivery Syst
Slide 10: Our DX Strategy
Our DX Strategy Create new value through collaboration across divisions, diseases, and products DX in hospitals DX in prognostic / chronic fields Develop safe and efficient drug delivery solutions Increase product value and develop new markets in chronic disease and post-care area Physician Linking
Slide 11: Business Expansion to Pharmaceutical Companies
Pharmaceutical Solutions Business Expansion to Pharmaceutical Companies Beyond GS26 Develop innovative that GS26 maximize drug effectiveness Develop solutions that As is improve drug effectiveness Develop solutions that improve drug safety and efficiency Drug delivery solutions for Filling technolog
Slide 12: Global expansion
Global business Solutions Global expansion Develop markets selectively in areas where we can leverage the strengths of each business Hospital Care Life Care Pharmaceutical Solutions Solutions Solutions Southeast Asia Europe Global Accelerate development of Consider expansion of insulin pharmaceutica
Slide 13: From General Hospital to Medical Care Solutions Company
From General Hospital to Medical Care Solutions Company Medical Care Solutions Company Hospital Care Life Care Pharmaceutical Solutions Solutions Solutions Division Division Division Formerly known as • GHP Group • DM・HC Group • Alliance • Pharma Group Division ©TERUMO CORPORATION 13 / 17
Slide 14: Pharmaceutical Solutions: Operation strategy
Operation strategy Accelerate capacity expansion to handle contracted deals Main factory and products Investment results and plan Pharmaceutical Solutions 80 B JPY Kofu Pharma NESP Factory 60 Yamaguchi Hulio Factory Teribone (2016~) 40 20 New factory Global Mega (2025~) deals 0 FY07~11 FY12~16 FY17~
Slide 15: Product pipeline
Product pipeline Short-to mid-term pipeline (FY22~24) Mid- to long-term pipeline (FY25~) • New PIVC • Next-generation Smart Pump • New dialysis Hospital Care Solutions • Expansion of CSTD lineup • Oncology supportive care products • New automatic peritoneal dialysis • Pharmaceutical nutrients mach
Slide 16: Revenue and Profit Overview
Revenue and Profit Overview Revenue Adjusted Operating Profit Mid single-digit growth Exceeding revenue growth FY16 FY21 FY26 FY16 FY21 FY26 Pharmaceutical Solutions: + 30~40 B JPY Expand Pharmaceutical Solutions business Life Care Solutions: + 6~10 B JPY Improve Pharmaceutical Solutions’ gr
Slide 17: Toward the next decade
Toward the next decade Beyond GS26 GS26 Create new value through digitalization Accelerate digitalization and introduce new ▪ Expand DM product portfolio and start to develop a DM business model ecosystem with partners ▪ Monetize service business to hospitals ▪ Initiate solution business to hospital
Slide 18: <“TERUMO
<“TERUMO Si/Ahead (00